Unlike in type 2 diabetes however, patients with NDM due to KATP channel mutations who are treated with sulphonylurea therapy have near normalization of glycated hemoglobin (HbA1c) without significant hypoglycaemia, suggesting that insulin secretion is well regulated [1,12]. This evidence concerns the gene INS and type 2 diabetes mellitus.